US Dry Powdered Inhaler Market Size | COVID-19 Impact Analysis | Forecast to 2025

The US dry powdered inhaler market is anticipated to grow at a substantial rate of around 1.2% during the forecast period. The major factors that are contributing significantly to the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of dry powdered inhaler market in the US. Further, the increasing demand for inhaler due to increasing COPD and asthma patients in the US has endorsed the approval of cohesive reimbursement policies in the US, is further fueling the growth of the market. The US the major market in the North American region due to greater healthcare expenditure and a higher prevalence rate of respiratory diseases.

To Request a Sample of our Report on US Dry Powdered Inhaler Market:  https://www.omrglobal.com/request-sample/us-dry-powdered-inhaler-market

The US dry powdered inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhaler are analyzed. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. 

(Get 15% Discount on Buying this Report)

A full Report of US Dry Powdered Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/us-dry-powdered-inhaler-market

US Dry Powdered Inhaler Market Segmentation

By Type

·        Preventive Inhaler

·        Reliever Inhaler

·        Long Acting Bronchodilators Inhaler 

By Application

·        Asthma 

·        Chronic Obstructive Pulmonary Disease (COPD)

By End-User

·        Homecare

·        Hospitals and Clinics

(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)